Hua Q, Li Z, Weng Y, Wu Y, Zheng L
Front Med. 2025; .
PMID: 40048137
DOI: 10.1007/s11684-025-1124-8.
Long L, Tao Y, Yu W, Hou Q, Liang Y, Huang K
Sci Rep. 2025; 15(1):7502.
PMID: 40033021
PMC: 11876657.
DOI: 10.1038/s41598-025-92518-3.
Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X
Signal Transduct Target Ther. 2025; 10(1):57.
PMID: 39979279
PMC: 11842613.
DOI: 10.1038/s41392-025-02148-4.
Ding Y, Chen Y, Xie S, Qiu Q, Guo X, Feng Y
Front Immunol. 2025; 15():1404768.
PMID: 39835121
PMC: 11743568.
DOI: 10.3389/fimmu.2024.1404768.
Mora-Lagos B, Reyes M, Lobos-Gonzalez L, Del Campo M, Buchegger K, Zanella L
Biol Res. 2025; 58(1):4.
PMID: 39827154
PMC: 11748569.
DOI: 10.1186/s40659-024-00581-3.
Regulation of ROS signaling by TIGAR induces cancer-modulating responses in the tumor microenvironment.
Cheung E, Strathdee D, Stevenson D, Coomes J, Blyth K, Vousden K
Proc Natl Acad Sci U S A. 2024; 121(50):e2416076121.
PMID: 39636862
PMC: 11648893.
DOI: 10.1073/pnas.2416076121.
Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies.
Ma Y, Sun Y, Guo H, Yang R
Front Immunol. 2024; 15:1418131.
PMID: 39606239
PMC: 11599180.
DOI: 10.3389/fimmu.2024.1418131.
Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies.
Zhu C, Liao J, Liu Y, Chen Z, Chang R, Chen X
Mol Cancer. 2024; 23(1):254.
PMID: 39543660
PMC: 11562679.
DOI: 10.1186/s12943-024-02171-z.
Biological Roles and Clinical Therapeutic Applications of Tumor-Associated Macrophages in Colorectal Liver Metastasis.
Li S, Hao L, Hu X
J Inflamm Res. 2024; 17:8429-8443.
PMID: 39529996
PMC: 11552512.
DOI: 10.2147/JIR.S493656.
The MicroRNA miR-223 Constrains Colitis-associated Tumorigenesis by Limiting Myeloid Cell Infiltration and Chemokine Expression.
Flynn C, Markey G, Neudecker V, Farrelly C, Furuta G, Eltzschig H
J Immunol. 2024; 213(12):1869-1883.
PMID: 39485006
PMC: 11611642.
DOI: 10.4049/jimmunol.2400129.
CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages.
Pietrobono S, Bertolini M, De Vita V, Sabbadini F, Fazzini F, Frusteri C
NPJ Precis Oncol. 2024; 8(1):246.
PMID: 39478186
PMC: 11525688.
DOI: 10.1038/s41698-024-00742-3.
Cold and hot tumors: from molecular mechanisms to targeted therapy.
Wu B, Zhang B, Li B, Wu H, Jiang M
Signal Transduct Target Ther. 2024; 9(1):274.
PMID: 39420203
PMC: 11491057.
DOI: 10.1038/s41392-024-01979-x.
Stimulator of interferon gene facilitates recruitment of effector CD8 T cells that drive neurofibromatosis type 1 nerve tumor initiation and maintenance.
Pundavela J, Dinglasan S, Touvron M, Hummel S, Hu L, Rizvi T
Sci Adv. 2024; 10(42):eado6342.
PMID: 39413183
PMC: 11482331.
DOI: 10.1126/sciadv.ado6342.
The Laws of Attraction: Chemokines as Critical Mediators in Cancer Progression and Immunotherapy Response in Bladder Cancer.
Hassouneh Z, Kim M, Bowman N, Rao M, Zhang N, Huang G
Cancers (Basel). 2024; 16(19).
PMID: 39409924
PMC: 11648100.
DOI: 10.3390/cancers16193303.
Blockade of CCR5 T Cell Accumulation in the Tumor Microenvironment Optimizes Anti-TGF-β/PD-L1 Bispecific Antibody.
Yi M, Li T, Niu M, Wu Y, Zhao B, Shen Z
Adv Sci (Weinh). 2024; 11(43):e2408598.
PMID: 39303165
PMC: 11578335.
DOI: 10.1002/advs.202408598.
Correlation of Immunomodulatory Cytokines with Tumor Volume and Cerebrospinal Fluid in Vestibular Schwannoma Patients.
Becker A, Scholle L, Klause C, Staege M, Strauss C, Otto M
Cancers (Basel). 2024; 16(17).
PMID: 39272860
PMC: 11394145.
DOI: 10.3390/cancers16173002.
Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma.
Luo H, Ikenaga N, Nakata K, Higashijima N, Zhong P, Kubo A
J Exp Clin Cancer Res. 2024; 43(1):258.
PMID: 39261943
PMC: 11389261.
DOI: 10.1186/s13046-024-03178-6.
Drug resistance and tumor immune microenvironment: An overview of current understandings (Review).
Liu Y, Liang J, Zhang Y, Guo Q
Int J Oncol. 2024; 65(4).
PMID: 39219258
PMC: 11387120.
DOI: 10.3892/ijo.2024.5684.
Establishment of a chemokine-based prognostic model and identification of CXCL10+ M1 macrophages as predictors of neoadjuvant therapy efficacy in colorectal cancer.
Tuersun A, Huo J, Lv Z, Zhang Y, Chen F, Zhao J
Front Immunol. 2024; 15:1400722.
PMID: 39170612
PMC: 11335547.
DOI: 10.3389/fimmu.2024.1400722.
Molecular understanding and clinical aspects of tumor-associated macrophages in the immunotherapy of renal cell carcinoma.
Liu H, Lv Z, Zhang G, Yan Z, Bai S, Dong D
J Exp Clin Cancer Res. 2024; 43(1):242.
PMID: 39169402
PMC: 11340075.
DOI: 10.1186/s13046-024-03164-y.